MYX 15.1% $5.10 mayne pharma group limited

PROJECTED $28 million EBITDA +ve in FY24, page-8

  1. 157 Posts.
    lightbulb Created with Sketch. 19
    MYX has a proven track record of failure. After almost 6 years of waiting patiently this last report was the nail in the coffin for me. Big losses experienced also. More big write downs coming. I'll be surprised if MYX is around in 3 - 5 years time.

    I would encourage any retail investor contemplating buying into MYX to take a lesson from long suffering shareholders here; do not trust a company that has proven track record of failure and empty promises.

    Goodbye MYX
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$5.10
Change
0.670(15.1%)
Mkt cap ! $433.8M
Open High Low Value Volume
$4.61 $5.20 $4.61 $1.883M 381.9K

Buyers (Bids)

No. Vol. Price($)
1 996 $5.02
 

Sellers (Offers)

Price($) Vol. No.
$5.11 420 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.